Asa

NURS 2516 Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name

Trade Name

Classification

ASA

Bayer Aspirin

Salicylates

Peak

Onset

Duration

1-3 hr

5-30 min

3-6 hr

Mechanism of action and indications (Why med ordered)

Dose

Route

Time/frequency

325 mg

po

0900 qd

For IV meds, compatibility with IV drips and /or solutions

Nursing Implications (what to focus on) Contraindications/warnings/interactions

Decreases platelet aggregation, CVA

Hypersensitivity to aspirin, tartrazine (FDC yellow dye #5), or other salicylates Cross-sensitivity with other NSAIDs may exist (less with nonaspirin salicylates) Bleeding disorders or thrombocytopenia (more important with aspirin)

Common side effects

dyspepsia, epigastric distress, heartburn, nausea

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically)

Lab value alterations caused by medicine May cause ↑ serum AST, ALT, and alkaline phosphatase, especially when plasma concentrations exceed 25 mg/100 ml. May alter results of serum uric acid, urine vanillylmandelic acid (VMA), protirelin-induced thyroid-stimulating hormone (TSH), urine hydroxyindoleacetic acid (5-HIAA) determinations, and radionuclide thyroid imaging. May cause ↓ serum potassium and cholesterol concentrations.

Be sure to teach the patient the following about this medication

Advise patients receiving aspirin prophylacticallyto take only prescribed dose. Increasing the dose has not been found to provide additional benefits. Instruct patient to take salicylates with a full glass of water and to remain in an upright position for 15-30 min after administration.

Nursing Process- Assessment (Pre-administration assessment) Patients who have asthma, allergies, and nasal polyps or who are allergic to tartrazine are at an increased risk for developing hypersensitivity reactions

Assessment Why would you hold or not give this med? onset of tinnitus, headache, hyperventilation, agitation, mental confusion, lethargy, diarrhea, and sweating.

Evaluation Check after giving Prevention of CVA